Lifecore Biomedical, Inc.
LFCR · NASDAQ
9/30/2025 | 5/25/2025 | 2/23/2025 | 11/24/2024 | |
|---|---|---|---|---|
| Market Cap | – | $248,816 | $207,315 | $256,331 |
| - Cash | $18,856 | $8,265 | $5,417 | $9,455 |
| + Debt | $136,218 | $130,823 | $130,341 | $131,340 |
| Enterprise Value | – | $371,374 | $332,239 | $378,216 |
| Revenue | $31,109 | $36,444 | $35,154 | $32,564 |
| % Growth | -14.6% | 3.7% | 8% | – |
| Gross Profit | $7,791 | $13,982 | $9,845 | $11,084 |
| % Margin | 25% | 38.4% | 28% | 34% |
| EBITDA | -$7,126 | $6,321 | -$7,220 | $981 |
| % Margin | -22.9% | 17.3% | -20.5% | 3% |
| Net Income | -$9,991 | -$1,147 | -$14,769 | -$6,571 |
| % Margin | -32.1% | -3.1% | -42% | -20.2% |
| EPS Diluted | -0.29 | -0.055 | -0.47 | -0.25 |
| % Growth | -424.4% | 88.2% | -88% | – |
| Operating Cash Flow | $1,762 | $5,347 | $1,200 | -$6,110 |
| Capital Expenditures | -$1,737 | -$2,097 | -$5,456 | -$2,470 |
| Free Cash Flow | $25 | $3,250 | -$4,256 | -$8,580 |